CD69 and Stroke: In humans, the microRNA (miRNA) profile of peripheral NK cells is altered after stroke and inhibition of miRNA-451a and miRNA-122-5p partially restored CD69 and NKG2D expression, suggesting that targeting miRNAs may alleviate immunosuppression observed after a stroke (51).